Latest
News
..........................................
February 2nd, 2012
Oculus Innovative Sciences Reports Fiscal Third Quarter 2012 Financial Results
|
January 19th, 2012
Oculus Innovative Sciences Announces Fiscal Third Quarter 2012 Financial Results and Conference Call
|
December 29th, 2011
Oculus Innovative Sciences to Present at Biotech Showcase 2012 in San Francisco
|
December 23rd, 2011
Oculus Innovative Sciences, Inc. to Raise Approximately $2.0 Million in Registered Direct Offering
|
November 3rd, 2011
Oculus Innovative Sciences Reports Record Fiscal Second Quarter 2012 Financial Results
|
October 21st, 2011
Oculus Innovative Sciences Announces Fiscal Second Quarter 2012 Financial Results and Conference Call
|
September 20th, 2011
Oculus Innovative Sciences Licenses Global Rights for Endotracheal Tube From National Institutes of Health to Reduce Ventilator-Associated Pneumonia
|
August 4th, 2011
Oculus Innovative Sciences Reports Record First Quarter Financial Results
|
July 27th, 2011
Oculus Innovative Sciences, Inc. Announces a Multi-Year Licensing Agreement With Eloquest Healthcare(R) for Microcyn(R)-Based Wound Care Products
|
July 21st, 2011
Oculus Innovative Sciences Announces Fiscal First Quarter 2012 Financial Results and Conference Call
|
More »
..........................................
|
The Middle East market is now served by our production facility in Mexico. Exclusive distribution of the Microcyn®-based products in the Middle East countries of United Arab Emirates; Saudi Arabia; Bahrain; Kuwait; Oman; Qatar; Egypt; Jordan; Lebanon; Algeria; Morocco; Tunisia; Mauritania; Iraq; Pakistan and Turkey is facilitated by Joseph and Gionis International.
If interested in becoming a sub-distributor, please click
here for the sub-distributor
application form. |
